UNSPSC 51332844: Chlorpromazine sulfone

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H19ClN2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6148VKM65V, chemically known as 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl-, 5,5-dioxide, but more generally known as chlorpromazine sulfone, which bears US NIH Compound Identifier 165214. European Medicines Agency schedules chlorpromazine sulfone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06208MIG.

Most nations, for tariff purposes, schedule chlorpromazine sulfone under HS 29343090. SMILES: CN(C)CCCN1C2CCCCC2S(=O)(=O)C3C1CC(CC3)CL.

UNSPSC 51332844 Chlorpromazine sulfone is a Commodity code that in practice state and local governments do not procure under this specific pharmaceutical ingredient designation. Recent state and local solicitations tagged with or near this code actually seek naloxone, safe drug deactivation systems, and broad-based generic multi-source pharmaceuticals and over-the-counter products rather than chlorpromazine sulfone specifically. The code appears to represent a narrow chemical compound unlikely to be the subject of direct state or local procurement solicitations, which instead target finished pharmaceutical products, drug-disposal systems, or pharmacy benefit management arrangements. Issuing bodies in the recent opportunities include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state, county, and local facilities across multiple states including Oregon). The issuing-body mix spans traditional procurement arms of state departments and county health agencies as well as cooperative purchasing vehicles that aggregate demand across multiple jurisdictions.

Recent activity concentrates in Florida and Texas with broader multistate cooperative purchasing extending across the upper Midwest and Pacific Northwest. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (posted June 30, 2026, due July 26, 2023) with quarterly deliveries and fixed-fee pricing; Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs (posted April 3, 2026) to explore pharmacy benefit innovation; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026) establishing multiple awards through authorized wholesalers effective July 1, 2026. The code shows little relevant recent activity directly aligned with chlorpromazine sulfone procurement, suggesting either misclassification in the tagging system or minimal state and local demand for this specific pharmaceutical ingredient as a standalone procurement line item.